Period of submission

Monday, September 30th - Friday, November 29th
*Notification of acceptance or rejection will be sent via email in March, 2025.

Type of Presentation

The author can choose a preferred type of presentation. Please be advised that the Program Committee will make the final decision on the type of presentations　regardless of your preference.

• Oral Presentation
• Poster Presentation
• Either will be fine

Abstract submission guidelines

• Please register by clicking the "abstract submission" button at the bottom of the page. Once the submission is completed, a confirmation email will be automatically. If you do not receive the confirmation e-mail within 24 hours after submission, please contact the Congress Secretariat (jspn121@congre.co.jp).
• You can revise your abstract as many times as you like during the abstract registration period.

Submission Guideline

• Title: up to 100 characters in single byte
• Body of abstract: up to 300 words in single byte
• Co-authors: up to 30 persons
• Affiliations: up to 10 affiliations

Categories

Please choose the category for your paper.
*Up to 3 categories can be registered.
*You are required to choose at least 1 category.

01	Schizophrenia and related disorders	24	Neuropathology
02	Mood disorders	25	Genetics and molecular genetics
03	Neurotic disorders and related disorders	26	Epidemiology
04	Personality disorders	27	Community mental health services
05	Epilepsy	28	Emergency psychiatry
06	Dementia	29	Complications of physical illness in patients with mental illness
07	Behavioural syndromes associated with physiological disturbances and physical factors	30	Consultation-liaison psychiatry
08	Organic and symptomatic mental disorders	31	Psychiatric diagnosis
09	Substance abuse and dependence	32	Symptomatology
10	Mental disorders in childhood and adolescence	33	Pharmacotherapy
11	Perinatal menal health	34	Psychotherapy
12	Sleep disorders	35	Psychosocial therapy/psychoeducation
13	Mental retardation	36	ECT/TMS/neuromodulation
14	Mental disorders in old age	37	Laboratory tests/biomarkers
15	Gender and mental health	38	Neuroimaging
16	Forensic psychiatry	39	Animal model/basic research
17	Forensic psychiatry	40	Suicide prevention
18	Medical education	41	Occupational mental health
19	Psychopathology	42	Social psychiatry
20	Neuropsychology	43	Emerging infectious diseases (such as COVID-19)
21	Neurophysiology	44	AI
22	Psychopharmacology	45	Treatment-refractory severe mental disorders
23	Neurochemistry	46	Others

 

Personal Information Protection

Please read and agree to the "Handling of personal information" in the form.

Congress Secretariat:
Congrès Inc.
Nakanoshima Qross 4-3-51 Nakanoshima, Kita-ku, Osaka 〒530-0005, Japan
TEL: +81-6-7653-3188
E-mail: jspn121@congre.co.jp